1. Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study. (4th May 2017) Authors: Pollack, Charles V.; Bernstein, Richard; Dubiel, Robert; Reilly, Paul; Gruenenfelder, Fredrik; Huisman, Menno V.; Kam, Chak-Wah; Kleine, Eva; Levy, Jerrold H.; Sellke, Frank W.; Steiner, Thorsten; Ustyugova, Anastasia; Weitz, Jeffrey I. Journal: Journal of medical economics Issue: Volume 20:Number 5(2017) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗